Search

everythinglearnresearchcommunity

for

Search:↓

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Finasteride safely lowers DHT levels without affecting testosterone.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

New treatments for PCOS focus on managing symptoms and improving fertility.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.